EMILY DANA BETHEA M.D.
Prescription History 1972898021
Internal Medicine - Gastroenterology in Boston, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for EMILY DANA BETHEA M.D., an active Gastroenterology specialist practicing in Boston, MA. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 223 documented patient claims. Among these therapy options, the most frequently utilized medication is Ursodiol, which accounts for 47 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Ursodiol | 47 | $256.72 | ▲ More than typical |
About Ursodiol: Ursodiol is used to dissolve certain types of gallstones, to prevent gallstones from forming in obese patients who are losing weight rapidly, and to treat a certain type of liver disease (primary biliary cholangitis). Show more ▾ Ursodiol is a bile acid. An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. In 2024, this provider wrote 47 Medicare prescriptions for Ursodiol, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (33.4). Medicare paid an average of $256.72 per fill, versus $163.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 119 30-Day Fills standardized to 30-day supplies 3,548 Days of Medication total across all patients in 2024 | |||
| Prednisone | 27 | $6.81 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 27 Medicare prescriptions for Prednisone, about 61% of the volume of the typical Massachusetts prescriber of this medication (44.4). Medicare paid an average of $6.81 per fill, versus $4.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43 30-Day Fills standardized to 30-day supplies 1,268 Days of Medication total across all patients in 2024 | |||
| Tacrolimus | 25 | $79.97▼ below MA avg | ▼ Less than typical |
About Tacrolimus: This form of tacrolimus is used on the skin to treat a skin condition called eczema (atopic dermatitis) in patients who have not responded well to (or should not use) other eczema medications. Show more ▾ Eczema is an allergic-type condition that causes red, irritated, and itchy skin. This drug works by weakening the skin's defense (immune) system, thereby decreasing the allergic reaction and relieving the eczema. Tacrolimus belongs to a class of drugs known as topical calcineurin inhibitors (TCIs). For children 2 to 15 years of age, the lower strength product should be used. This medication is not recommended if you have a history of a certain rare genetic disorder (Netherton's syndrome). Also, this medication should not be used by anyone who has a weakened immune system (for example, following an organ transplant). A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. In 2024, this provider wrote 25 Medicare prescriptions for Tacrolimus, about 66% of the volume of the typical Massachusetts prescriber of this medication (37.6). Medicare paid an average of $79.97 per fill, versus $126.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 69 30-Day Fills standardized to 30-day supplies 2,070 Days of Medication total across all patients in 2024 | |||
| Entecavir | 22 | $362.28 | ≈ Typical |
About Entecavir: See also Warning section. Show more ▾ Entecavir is used to treat long-term hepatitis B infection. Hepatitis B is an infection of the liver caused by the hepatitis B virus. Long-term infection can cause liver damage, rarely liver cancer, and liver failure. Entecavir helps to decrease the amount of hepatitis B virus in your body. It is unknown if this medication lowers your chance of getting liver cancer or liver damage. Entecavir is an antiviral that belongs to a class of drugs known as hepatitis B virus nucleoside reverse transcriptase inhibitors. Entecavir is not a cure for hepatitis B. It does not prevent the spread of the virus to others through sexual contact or blood/body fluid contamination (such as sharing used needles). In 2024, this provider wrote 22 Medicare prescriptions for Entecavir, about the same volume as the typical Massachusetts prescriber of this medication (23.7). Medicare paid an average of $362.28 per fill, versus $258.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46 30-Day Fills standardized to 30-day supplies 1,380 Days of Medication total across all patients in 2024 | |||
| Furosemide | 19 | $4.04▼ below MA avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2024, this provider wrote 19 Medicare prescriptions for Furosemide, about a quarter of the volume of the typical Massachusetts prescriber of this medication (72.4). Medicare paid an average of $4.04 per fill, versus $5.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2024 | |||
| Mycophenolate Mofetil | 19 | $298.92 | ▼ Less than typical |
About Mycophenolate Mofetil: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2024, this provider wrote 19 Medicare prescriptions for Mycophenolate Mofetil, about 67% of the volume of the typical Massachusetts prescriber of this medication (28.4). Medicare paid an average of $298.92 per fill, versus $132.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,650 Days of Medication total across all patients in 2024 | |||
| Spironolactone | 16 | $5.81▼ below MA avg | ▼ Less than typical |
About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a "water pill" (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) In 2024, this provider wrote 16 Medicare prescriptions for Spironolactone, about a third of the volume of the typical Massachusetts prescriber of this medication (40.1). Medicare paid an average of $5.81 per fill, versus $9.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| VemlidyTenofovir Alafenamide | 14 | $1,409.88▼ below MA avg | ▼ Less than typical |
About Vemlidy: Tenofovir alafenamide is used to treat chronic hepatitis B infection, a viral infection of the liver. Show more ▾ It works by stopping or slowing the growth of the virus. Chronic hepatitis infection can lead to serious liver damage (cirrhosis) and liver cancer. It is not known if tenofovir alafenamide can cure hepatitis B or can prevent you from passing the virus to others. Practice "safer sex" (such as the use of latex condoms) to lower the risk of passing the virus to others. Component of Biktarvy. In 2024, this provider wrote 14 Medicare prescriptions for Vemlidy, about half the volume of the typical Massachusetts prescriber of this medication (29.7). Medicare paid an average of $1,409.88 per fill, versus $1,469.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 12 | $26.67 | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 12 Medicare prescriptions for Omeprazole, about 12% of the volume of the typical Massachusetts prescriber of this medication (97.3). Medicare paid an average of $26.67 per fill, versus $15.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $12.24▼ below MA avg | ▼ Less than typical |
About Gavilyte-G: PEG (polyethylene glycol) with electrolyte is used to clean out the intestines before certain bowel exam procedures such as colonoscopy or barium enema X-rays. Show more ▾ It is a laxative that works by drawing large amounts of water into the colon. This effect results in watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure. In 2024, this provider wrote 11 Medicare prescriptions for Gavilyte-G, about 16% of the volume of the typical Massachusetts prescriber of this medication (69.3). Medicare paid an average of $12.24 per fill, versus $15.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 11 30-Day Fills standardized to 30-day supplies 11 Days of Medication total across all patients in 2024 | |||
| Mycophenolic AcidMycophenolate Sodium | 11 | $216.78 | ▼ Less than typical |
About Mycophenolic Acid: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted kidney. Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new kidney as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2024, this provider wrote 11 Medicare prescriptions for Mycophenolic Acid, about half the volume of the typical Massachusetts prescriber of this medication (23.4). Medicare paid an average of $216.78 per fill, versus $201.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for EMILY DANA BETHEA M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Gastroenterology prescribing approach at this Boston, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
